A novel strategy for drug discovery and advancement has been developed by exploiting viral genomics. By manipulating cell function through the therapeutic administration of specific gene products from viruses, an important new class of therapeutics could be developed for the treatments of major human diseases. As it may turn out in the human genome arena, the groups which can establish a stronghold in the field would be in the best position to exploit this new drug development strategy.